You are here

This Antibiotic Drug May Disrupt the Formation of Fears and Negative Thoughts

Post-Traumatic Stress Disorder surfaces in people who have had experienced a traumatic, shocking event. Trauma triggers a host of changes in human body. Fear, when coupled with trauma can lead to a difficulty in dealing with the initial symptoms of stress. Those who take longer to get over the event – and continue to feel threatened, panicky or fearsome even after considerable time – can be diagnosed with PTSD. The symptoms and intensity of people with PTSD range from person to person. “Not every traumatized person develops ongoing (chronic) or…

Read More

Brazil issues first license for sale of a cannabis-based drug

Brazilian healthcare regulator Anvisa on Monday said it had issued the country’s first license for sale of a cannabis-based drug in the country after years of legal wrangling with patients. The multiple sclerosistreatment, an oral spray derived from marijuana and developed by Britain’s GW Pharmaceuticals PLC, is known as Sativex internationally and will be sold in Brazil under the brand name Mevatyl. The legal status of cannabis-based drugs has been a thorny issue in Brazil for years, with several patients fighting in the courts to circumvent prohibition. Anvisa has loosened…

Read More

New drug shows promise in repairing failing hearts

New drug shows promise in repairing failing hearts A new experimental drug has shown promise in restoring cardiac function after heart failure, according to results of an early human trial. The researchers found that an infusion of the drug cimaglermin was generally tolerated except for transient nausea and headache. “These findings support continued clinical development of the investigational drug cimaglermin, including further safety evaluations and detailing the potential improvement on clinical heart failure outcome measures,” said lead author of the study Daniel Lenihan from Vanderbilt University in Nashville, Tennessee, US….

Read More

Laser therapy with deep-sea drug kills prostate cancer cells

A non-surgical treatment for lowrisk prostate cancer, in which doctors inject a light-sensitive drug derived from deep-sea bacteria into a patient’s bloodstream, was shown in a trial to kill cancer cells without destroying healthy tissue. Results of a trial in 413 patients showed that the drug, which is activated with a laser to destroy tumour tissue in the prostate, was so effective that half the patients went into remission, compared with 13.5% in a control group.”These results are excellent news for men with early localised prostate cancer, offering a treatment…

Read More

Breakthrough malaria drug likely by ’18

Breakthrough malaria drug likely by ’18 (Getty Images) Contrary to the perception that drug research is mostly focused around the diseases of the elite, the antimalarial drug pipeline has increased nearly three-fold since 2008, with at least three new medicines expected to be launched in two to five years. India, where a lot of clinical trials have already begun, is likely to get a breakthrough anti-malarial drug Tafenoquine by 2018. The drug, a one-day-two-dose treatment, has already entered phase-three trials and once approved will replace the current 14-day treatment for…

Read More

Wilson’s disease drug goes off the shelves

Wilson’s disease drug goes off the shelves A life-saving medicine D-Penicillamine, used in treatment of Wilson’s disease, is unavailable across the country, jeopardising lives of many patients. The shortage, primarily caused because of short supply of raw material used in the drug, prompted the drug regulator to call for an urgent meeting on Friday with five manufacturers of the drug. Wilson’s disease is a rare genetic disorder that prevents the body from getting rid of extra copper. The accumulation of copper may damage liver, brain, kidneys and eyes. D-Penicillamine is…

Read More